Phase IV Multicenter, Prospective, Open-Label Clinical Trial of Cenegermin (rhNGF) for Stage 1 Neurotrophic Keratopathy (DEFENDO)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Phase IV Multicenter, Prospective, Open-Label Clinical Trial of Cenegermin (rhNGF) for Stage 1 Neurotrophic Keratopathy (DEFENDO) ; volume:13 ; number:2 ; day:4 ; month:1 ; year:2024 ; pages:553-570 ; date:2.2024
Ophthalmology and therapy ; 13, Heft 2 (4.1.2024), 553-570, 2.2024
- Creator
-
Hamrah, Pedram
Massaro-Giordano, Mina
Schanzlin, David
Holland, Edward
Berdy, Gregg
Goisis, Giovanni
Pasedis, Georgea
Mantelli, Flavio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40123-023-00866-y
- URN
-
urn:nbn:de:101:1-2024032609492423041902
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hamrah, Pedram
- Massaro-Giordano, Mina
- Schanzlin, David
- Holland, Edward
- Berdy, Gregg
- Goisis, Giovanni
- Pasedis, Georgea
- Mantelli, Flavio
- SpringerLink (Online service)
Other Objects (12)
ProNGF/NGF in humanen Granulosazellen
Stellwerk Ngf
NGF news
Acupuncture for patients with mild hypertension: study protocol of an open-label multicenter randomized controlled trial
Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies
NGF und Anti-NGF-Autoantikörper : Serummarker psychiatrischer Erkrankungen?
Palonosetron versus ondansetron as rescue medication for postoperative nausea and vomiting: a randomized, multicenter, open-label study
Fast-track multidisciplinary treatment versus conventional treatment for colorectal cancer: a multicenter, open-label randomized controlled study
Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis
Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study
ProNGF/NGF in humanen Granulosazellen
Stellwerk Ngf
NGF news
Acupuncture for patients with mild hypertension: study protocol of an open-label multicenter randomized controlled trial
Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies
NGF und Anti-NGF-Autoantikörper : Serummarker psychiatrischer Erkrankungen?
Palonosetron versus ondansetron as rescue medication for postoperative nausea and vomiting: a randomized, multicenter, open-label study
Fast-track multidisciplinary treatment versus conventional treatment for colorectal cancer: a multicenter, open-label randomized controlled study
Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis
Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study
ProNGF/NGF in humanen Granulosazellen
Stellwerk Ngf
NGF news
Acupuncture for patients with mild hypertension: study protocol of an open-label multicenter randomized controlled trial
Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies
NGF und Anti-NGF-Autoantikörper : Serummarker psychiatrischer Erkrankungen?
Palonosetron versus ondansetron as rescue medication for postoperative nausea and vomiting: a randomized, multicenter, open-label study
Fast-track multidisciplinary treatment versus conventional treatment for colorectal cancer: a multicenter, open-label randomized controlled study
Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis